Is Invesco S&P SmallCap 600 Pure Value ETF (RZV) a Strong ETF Right Now?

The Invesco S&P SmallCap 600 Pure Value ETF (RZV), a smart beta fund with $209.5 million in assets under management and a 0.35% expense ratio, seeks to replicate the S&P SmallCap 600 Pure Value Index, with its largest allocation in Consumer Discretionary. Characterized as a high-risk option due to a 1.20 beta and 24.59% standard deviation, RZV has posted a -2.68% year-to-date return. While offering diversified small-cap value exposure, its cost and risk profile warrant consideration against larger, lower-expense alternatives such as the iShares Russell 2000 Value ETF (IWN) and Vanguard Small-Cap Value ETF (VBR).

Analysis

The Invesco S&P SmallCap 600 Pure Value ETF (RZV) is a smart beta fund offering targeted exposure to small-cap stocks with strong value characteristics. With $209.5 million in assets, it is an average-sized fund in its category. Its strategy results in a significant overweight to the Consumer Discretionary sector, which constitutes 26.9% of the portfolio. While the fund is diversified across 147 holdings, its top 10 positions account for a modest 17.72% of total assets. From a performance and risk perspective, RZV has underperformed year-to-date with a -2.68% return but shows a 4.65% gain over the last 12 months as of July 16, 2025. Critically, it is positioned as a high-risk investment, evidenced by a beta of 1.20 and a three-year standard deviation of 24.59%, indicating higher volatility than the broader market. Its 0.35% expense ratio is notably higher than those of larger, more liquid competitors like the iShares Russell 2000 Value ETF (IWN) at 0.24% and the Vanguard Small-Cap Value ETF (VBR) at a significantly lower 0.07%.

Key Decisions for Investors

• Investors with a high risk tolerance might consider RZV for tactical, pure-play exposure to the small-cap value factor, but should be prepared for its elevated volatility, as indicated by its 1.20 beta.
• For core strategic allocations, it is prudent to weigh RZV's 0.35% expense ratio against substantially cheaper and larger alternatives like VBR (0.07%) and IWN (0.24%), as the cost differential could impact long-term net returns.